IMPLICATIONS OF CARDIOVASCULAR DISEASES RELATED TO COVID-19 INFECTION: INTEGRATIVE REVIEW
Abstract
Introduction: When referring to COVID-19, the respiratory symptoms dominate the discussions and initial concerns of the population and health professionals, especially the development of severe acute respiratory distress syndrome. However, the cardiovascular system is greatly affected by these conditions, that is, being responsible for complications and mortality in these patients. Objectives: to identify scientific evidence on the association between cardiovascular diseases and COVID-19 infection. Methodology: an integrative review was conducted based on 10 articles in English, Portuguese, and Spanish, available on the PubMed, Lilacs, and Scielo platforms. The search strategy used terms obtained from DeCS and MESH and synonyms combined with Boolean operators (AND, OR). Results: The selected studies showed that cardiac complications associated with COVID-19 infection are related to acute myocardial infarction (AMI), myocarditis, heart failure, malignant arrhythmias, thrombotic disorders, especially in those with chronic comorbidities, exposed to cardiovascular risk factors or with cardiac dysfunction, increase in inflammatory cytokines, rupture of atheromas and myocardial injury. Conclusion: With the rapid spread of COVID-19, cardiovascular implications are common in patients with Sars-cov-2 and are at increased risk of morbidity and mortality. A thorough routine cardiac screening should be performed on patients who have been infected with COVID-19.
Â
Author Biographies
Centro Universitário Santo Agostinho
Centro Universitário Santo Agostinho
Possui graduação em Odontologia pela Universidade Federal do Piauà (1992), graduação em QuÃmica pela Universidade Federal do Piauà (1985) e doutorado em Biologia Celular e Molecular Aplicada à Saúde pela Universidade Luterana do Brasil (2016). Atualmente é policial militar: oficial da saúde- cirurgiã do Centro Universitário Santo Agostinho de Teresina, estatutária - PolÃcia Militar do PiauÃ, colaborador da Associação Brasileira de Cirurgiões Dentistas - Secção Piauà e tempo parcial do Centro Universitário Santo Agostinho. Tem experiência na área de Odontologia, com ênfase em Cirurgia Buco-Maxilo-Facial, atuando principalmente nos seguintes temas: enfermagem, fisioterapia.
References
ALVES, D. et al. Prevalence of comorbidities in Severe Acute Respiratory Syndrome in patients with COVID-19 and other infectious agentes. Research, Society and Development, v. 9, n. 11, p. e70791110286, 2020. DisponÃvel em: Acesso em: 24 out. 2021 DOI: https://doi.org/10.33448/rsd-v9i11.10286
AMIR, M. et al. COVID-19 concomitant with infective endocarditis: A case report and review of management. Int J Infect Dis. Indonésia v. 98 p. 109-112, jun, 2020. DisponÃvel em: Acesso em: 20 mar. 2022 DOI: https://doi.org/10.1016/j.ijid.2020.06.061
BENITO, L. et al. Comorbidades e fatores de risco identificados em pessoas que vieram a óbito por SÃndrome Respiratória Aguda Grave por Covid-19. REVISA. 2021; v. 10 n. 3 p. 607-626. DisponÃvel em: Doi:https://doi.org/10.36239/revisa.v10.n3.p607a626 Acesso em: 30 abril 2022.
BRASIL. Ministério da saúde. Informe Técnico - MERS-CoV (Novo CoronavÃrus). Secretaria de vigilância em saúde. BrasÃlia 2014. DisponÃvel em: < Informe-Tecnico-para-Profissionais-daSaude-sobre-MERS-CoV-09-06-2014.pdf >. Acesso em: 14 set 2020.
CARDIOVASCULAR diseases. OPAS, 2021. DisponÃvel em: https://www.who.int/news-room/factsheets/detail/cardiovascular-diseases-(cvds Acesso em: 17, out. 2021.
CHENG, P. et al. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty. Curr Cardiol Rep. 2020 Apr v29 n. 22 p 34. DisponÃvel em: PMID: 32350632; PMCID: PMC7189178. Acesso em: 25 out. 2021 DOI: https://doi.org/10.1007/s11886-020-01293-2
COSTA, Isabela. et al. O Coração e a COVID-19: O que o Cardiologista Precisa Saber. Arquivos Brasileiros de Cardiologia [online]. 2020, v. 114, n. 5, pp. 805-816. DisponÃvel em: https://doi.org/10.36660/abc.20200279 . Acesso em: 25 out. 2021.
DANCY, L. et al. Predictive model of increased mortality and bed occupancy if thrombolysis becomes the initial treatment strategy for STEMI during the SARS-CoV-2 pandemic. Clinical Medicine, Londres, v. 20, n. 5, p.170-172, set, 2020. DisponÃvel em: 0293. Acesso em: 20 mar. 2022 DOI: https://doi.org/10.7861/clinmed.2020-
DE ALMEIDA, J. O., et al. COVID-19: Fisiopatologia e Alvos para Intervenção Terapêutica. Revista virtual de quÃmica. V.12, N.6, P.1464-1497. 17 Set 2020. DisponÃvel em: < http://static.sites.sbq.org.br/rvq.sbq.org.br/pdf/v12n6a10.pdf >. Acesso em: 12 out 2021.
DOENÇAS cardiovasculares continuam sendo principal causa de morte nas Américas. OPAS, 2021. DisponÃvel em: https://www.paho.org/pt/noticias/29-9-2021-doencas-cardiovascularescontinuam-sendo-principal-causa-morte-nas-americas . Acesso em: 16, out. 2021.
FAVARO, E. et al. Postoperative complications in adult patients undergoing surgery with confirmed infection by SARS-CoV-2: An integrative review. Rev. Latino-Am. Enfermagem. 2021; n.29 p.3496. DisponÃvel em: DOI: http://dx.doi.org/10.1590/1518-8345.5346.3496 Acesso em: 01 mai 2022;
GUIMARÃES, PO. et al. High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study. int j cardiol heart vasc. 2021 n.36 p.100853. DisponÃvel em: Epub 2021 Jul 30. PMID: 34345648; PMCID: PMC8321709. Acesso em: 30 abril 2022 DOI: https://doi.org/10.1016/j.ijcha.2021.100853
KEVIN, J. et al. COVID-19 and Cardiovascular Disease. CIRCULATION. V. 141, N.20 P.1648-1655 2020. DisponÃvel em: https://doi.org/10.1161/CIRCULATIONAHA.120.046941 Acesso em: 26 out. 2021.
LIZCANO F, ARROYAVE F. El ambiente, los desplazamientos y el riesgo cardiovascular en la pandemia por COVID-19. Sociedad colombiana de cardiologia & cirugia cardiovascular, Colômbia 2020, v.27, n. 3, p.160-165. Doi: ttps://doi.org/10.1016/j.rccar.2020.05.001. Acesso em: 27 Abril 2022.
MENDES, K. et al. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto – Enfermagem. 2008, v. 17, n. 4, p. 758-764. DisponÃvel em: <https://doi.org/10.1590/S0104-07072008000400018> Acesso em: 27 Mar. 2022.
MOCCIA, F. et al. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. GeroScience, 2020. V.42, P.1021–1049. DisponÃvel em: < https://doi.org/10.1007/s11357-020-00198-w> Acesso em: 27 abril 2022.
NASCIMENTO P. et al. Principais desfechos fatais em indivÃduos cardiopatas acometidos por COVID-19. Enfermagem em Foco, Espanha, 2020. v. 11, n. 2 p. 2177-4285. DisponÃvel em: <http://revista.cofen.gov.br/index.php/enfermagem/article/view/3676/982> Acesso em: 24 out. 2021.
ORGANIZAÇÃO Mundial da Saúde (OMS). Coronavirus disease 2019 (COVID-19). Genebra: OMS; 2020 [cited 2020 Jul 28]. Disponivel em: https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200728-covid-19-sitrep-190 pdf?sfvrsn=fec17314_2. Acesso em: 24 out.2021.
ORSI, F. et al. Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy. published online ahead of print, 2020. Hematol Transfus Cell Ther. V. 30070-5 N.20 P.2531-1379. Acesso em: 11 out, 2021.
STRABELLI T. M. G; Uip D.E; et al. covid-19 e o coração. Sociedade brasileira de cardiologia. V.114 N.4 P.598-600. 30 mar 2020 DisponÃvel em: < https://www.scielo.br/j/abc/a/NWKkJDxLthWSb53XFV9Nhvn/?lang=pt&format=pdf >. Acesso em: 11 out 2021.
VELAVAN TP, MEYER CG. The Covid-19 epidemic. Trop Med Int Health, 2020. N3, P.278-280. Disponivel em: < https://pubmed.ncbi.nlm.nih.gov/32052514/ >. Acesso em: 12 out 2021.
WALLENTIN, L. et al. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. European Heart Journal. Suécia, 2020. v.1 p.1-10. DisponÃvel em: <>. Acesso em: 30 Abril 2022 DOI: https://doi.org/10.1093/eurheartj/ehaa697
WANG D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. disponÃvel em: https://jamanetwork.com/journals/jama/articleabstract/2761044 . Acesso em: 26 out. 2021 DOI: https://doi.org/10.1001/jama.2020.1585
YANGJING, X; QINGHAI Y, et al. Impact of Cardiovascular Disease on Clinical Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19). Circulation Journal, 2020. China, v.84, p. 1277– 1283. DisponÃvel em: <>. Acesso em: 30 abril 2022 DOI: https://doi.org/10.1253/circj.CJ-20-0348
Zhang, Li, et al. Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, andCritical Care Echocardiography clinical perpective v.33 p. 676-682 jun, 2020. Disponivel em: < https://doi.org/10.1016.ECHO.2020.04.004 > Acesso em: 20 abril 2022.
ZHOU. F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 2020. China, v.395, n.10229, p.1054-1062. DisponÃvel em: < DOI:https://doi.org/10.1016/S0140-6736(20)30566-3> Acesso em: 29 abril 2022.
License
Copyright (c) 2022 RECIMA21 - Revista CientÃfica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veÃculo de divulgação, seguindo os padrões nacionais e internacionais de publicação.Â